Biocentury: Regeneron Using Interleukin Antibody Receptors for Asthma Medication

An estimated 25 million Americans suffer from Asthma, but current medications such as inhalers have been deemed ineffective for 10-20% of its users. Regneron (REGN) and Sanofi (SAN) have partnered to crease a new Asthma drug, Dupilumab.

Read more »

Company Snapshot — Fibrocell Science: Autologous Cell Therapy, Aesthetic Treatment

The fibroblast cell is known to play key roles in extracellular matrix synthesis, production of collagen, and production of growth factors all of which support the skin, soft tissues, and aid in wound healing. Fibrocell Science (FCSC) is an autologous cell therapy company whose sole focus is the development of aesthetic, medical, and scientific application that involve the use of the fibroblast cell.

Read more »

Company Snapshot — Oxygen Biotherapeutics: Tissue Oxygenation, Traumatic Brain Injury

Oxygen is one of the main elements vital to human survival. Oxygen Biotherapeutics’ (OXBT) mission is to research, develop, and market oxygen related products based on perflurocarbons technology. The team is driven to aid the human body in maintaining adequate oxygen levels to prevent disease and damage to tissues if oxygen flow were ever to be interrupted or inhibited.

Read more »

OneMedForumNY 2013, June 26-27

NEW YORK, October 3, 2012 – OneMedPlace has announced programming themes for its 6th Annual OneMedForum, taking place January 7-9th, 2013, at the Sir Francis Drake Hotel in San Francisco.

Read more »

PDUFA: Flamel Technologies S.A. — Undisclosed Product, May 31, 2013

Read more »

PUDFA: DepoMed, Inc. — Serada, May 31, 2013

Read more »

Earnings: Athersys Inc. — May 16, 2013

Read more »

MAPPING THE B.R.A.I.N.

On April 2nd, 2013, U.S. President Barack Obama unveiled the “BRAIN” Initiative, which is short for Brain Research through Advancing Innovative Neurotechnologies. The BRAIN Initiative may be known as the spiritual successor to the Human Genome Project, not only for its desire to understand a mysterious place known to medical science, but for taking its cues from the initial success of the HGP.

Read more »

Bioinformatics Special Report, Part I: Where Does Biotechnology Data Come From?

Bioinformatics is the field of science involved with using computational methods to convert raw biological data into meaningful biological paradigms. Part I of this article will discuss how bioinformatics data is generated. It will focus on the methods used to collect this data, and the companies that support this collection.

Read more »

Why Medical Device Manufacturers Must Engage in Politics

Editor’s Note: The following comes to us from media affiliate marcus evans. JC Scott, a speaker at the marcus evans […]

Read more »